Forecast & RatingOnly 1 analyst currently covers Redhill Biopharma (RDHL.US), with a price target of $1000.00 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Feb 17, 2023Price forecast
$1000.00173782.80%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateJul 3, 2023
Forecast met0.0%
Stock price$30.25
Avg. target$1,000.0
High target$1,000
Low target$1,000
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.